Corbus Pharmaceuticals Holding (US: CRBP) — Healthcare · Share Price, Chart & Market Data
About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $10.19 (+1.29%)
CRBPCorbus Pharmaceuticals Holding
Loading watchlist status…
Trade CRBP now
Corbus Pharmaceuticals Holding share price
CRBP price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 5:18 pm GMT+0
CRBP price performance
-1.02%
5D
16.992%
1M
29.479%
YTD
35.867%
1Y
CRBP price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 5:18 pm GMT+0
CRBP details
CRBP Market Signals